Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127238461 | 12723846 | 1 | I | 20160826 | 20160908 | 20160908 | EXP | US-ACORDA-ACO_127973_2016 | ACORDA | 0.00 | F | Y | 0.00000 | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127238461 | 12723846 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Unknown | UNK | U | U | 22250 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127238461 | 12723846 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127238461 | 12723846 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127238461 | 12723846 | Asthenia | |
| 127238461 | 12723846 | Decreased appetite | |
| 127238461 | 12723846 | Fibromyalgia | |
| 127238461 | 12723846 | Heart rate decreased | |
| 127238461 | 12723846 | Hypoaesthesia | |
| 127238461 | 12723846 | Insomnia | |
| 127238461 | 12723846 | Multiple sclerosis relapse | |
| 127238461 | 12723846 | Pain | |
| 127238461 | 12723846 | Paraesthesia | |
| 127238461 | 12723846 | Sciatica | |
| 127238461 | 12723846 | Syncope | |
| 127238461 | 12723846 | Vertigo | |
| 127238461 | 12723846 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |